Overview: Sickle-Cell Anemia Mutation TestIntroduction: The Sickle-Cell Anemia Mutation Test detects sickle cell mutations to diagnose anemia, causing fatigue or pain. Aligned with 2023 ASH guidelines, it uses PCR for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected sickle cell disease.
Other Names: Sickle Cell Mutation Assay, HBB Gene Test.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy.
Historical Milestone: Sickle cell mutation testing began in the 1980s with HBB gene discovery. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects sickle cell mutations to diagnose anemia, guides treatment, and evaluates patients with fatigue or pain.
Test Parameters: 1. Sickle Cell Mutation
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of fatigue, pain, or sickle cell symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, pain crises, or family history of sickle cell disease. Include current medications, especially hydroxyurea.
Consent: Written consent required, detailing the tests purpose, sickle cell anemia implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect HBB gene mutations. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for sickle cell diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or contamination can affect results. Sample quality impacts specificity.
Clinical Significance: Positive HBB mutation confirms sickle cell anemia, guiding hydroxyurea or transfusion therapy. Negative results may require hemoglobin electrophoresis.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Hemoglobin electrophoresis, CBC, or reticulocyte count to confirm sickle cell diagnosis.
Test Limitations: Specific to HBB mutations; other hemoglobinopathies may be missed. Clinical correlation is needed.
References: ASH Sickle Cell Guidelines, 2023; Blood, Piel FB, 2022.
